| 标题 |
Daratumumab + Bortezomib/Lenalidomide/Dexamethasone (D-VRd) in Transplant-Eligible (TE) Patients With Newly Diagnosed Myeloma (NDMM): Analysis of the Phase 3 PERSEUS Study Based on High-Risk Cytogenetic Abnormalities (HRCAs) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lymphoma Myeloma and Leukemia 作者:Meletios A. Dimopoulos; Pieter Sonneveld; Paula Rodriguez-Otero; Hang Quach; P. Joy Ho; et al 出版日期:2024-08-27 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)